GlassScriptPhysician profile
Rachel B Head
NPI 1407084114
$4,309.96
in general payments reported to CMS, 2019-2025
28 companies · $477 in 2025
The $477 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.78 · 2020: $246 · 2021: $1,234 · 2022: $1,398 · 2023: $403 · 2024: $470 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,350.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,434.27 | 2022-2024 | Interstim |
| Teleflex LLC | $1,352.88 | 2021-2025 | Barrigel, Urolift |
| Axonics, INC. | $237.44 | 2020-2024 | Axonics |
| Sumitomo Pharma America, INC. | $187.44 | 2023-2024 | Gemtesa |
| Endo Pharmaceuticals INC. | $163.13 | 2019-2024 | Xiaflex, Aveed |
| Astellas Pharma US INC | $115.61 | 2022-2023 | Myrbetriq |
| Antares Pharma, INC. | $102.31 | 2023-2025 | Xyosted, Tlando, Nocdurna |
| Procept Biorobotics Corporation | $100.68 | 2020-2025 | Aquabeam Robotic System, Aquabeam System |
| Boston Scientific Corporation | $100.60 | 2019-2025 | Spaceoar Vue System - 10ml |
| Abbvie INC. | $69.12 | 2022-2025 | |
| Avation Medical, INC. | $45.89 | 2025 | Vivally System |
| Neotract INC. | $42.33 | 2019-2020 | |
| Convatec INC. | $39.06 | 2019-2023 | |
| Endo USA, INC. | $32.03 | 2025 | Xiaflex |
| Pfizer INC. | $30.65 | 2023 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $29.77 | 2021-2022 | |
| Coloplast Corp | $27.62 | 2019-2021 | |
| Urogen Pharma, INC. | $22.28 | 2023 | Jelmyto |
| C. R. Bard, INC. & Subsidiaries | $21.28 | 2021 | |
| Cook Medical LLC | $20.02 | 2019 | |
| Ambu INC. | $19.37 | 2020 | |
| Accord Healthcare, INC. | $19.14 | 2022 | |
| Myovant Sciences INC. | $17.83 | 2021 | |
| Bioprotect Medical, INC. | $17.08 | 2025 | Bioprotect Balloon Implant System |
| Laborie Medical Technologies Corp. | $16.83 | 2022 | |
| Janssen Biotech, INC. | $16.78 | 2025 | Erleada |
| Allergan, INC. | $15.17 | 2021 | |
| Olympus America INC. | $13.35 | 2024 | Itind System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Head listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.